Management of Abnormal Liver Enzymes
When a patient presents with abnormal liver lab work, specifically elevated liver enzymes, the clinician should not simply repeat the same panel of tests but should immediately pursue a diagnostic workup to determine the underlying cause, as 84% of abnormal liver tests remain abnormal after one month and 75% remain abnormal even after two years. 1
Initial Assessment
- Determine if there are any red flags requiring immediate referral: unexplained clinical jaundice or suspicion of hepatic/biliary malignancy 1
- Evaluate the pattern of liver enzyme elevation to distinguish between:
Comprehensive History
- Age, ethnicity, and country of birth (to assess risk for hepatitis B or C) 1
- Specific symptoms: jaundice, abdominal pain, weight loss, pruritus 1
- Medication review: prescribed medications, over-the-counter drugs, herbal supplements 1
- Alcohol consumption history (current and past intake in average units per week, consider AUDIT-C screening) 1
- Risk factors for metabolic syndrome: central obesity, hypertension, diabetes/insulin resistance, dyslipidemia 1
- Travel history, occupational exposures, tick bites, muscle injury 1
- Family history of liver disease 1
Physical Examination
- Body mass index calculation 1
- Abdominal examination for hepatosplenomegaly, ascites, and other signs of chronic liver disease 1
- Signs of jaundice, spider angiomas, palmar erythema, or other stigmata of liver disease 1
Laboratory Evaluation
Standard liver aetiology screen (core panel) should include: 1
- Abdominal ultrasound
- Hepatitis B surface antigen
- Hepatitis C antibody (with PCR follow-up if positive)
- Anti-mitochondrial antibody
- Anti-smooth muscle antibody
- Antinuclear antibody
- Serum immunoglobulins
- Serum ferritin and transferrin saturation
For marked ALT elevations (>1000 U/L), consider additional testing for: 1
- Hepatitis A
- Hepatitis E
- Cytomegalovirus
Special Considerations
- For patients with cholestatic liver enzymes and personal/family history of autoimmune disease or inflammatory bowel disease, consider primary sclerosing cholangitis (PSC) 1
- For patients on medications known to cause liver injury (e.g., statins, methotrexate), evaluate for drug-induced liver injury 3
- For patients on methotrexate with abnormal liver enzymes: 1
- If elevation is <3-fold the upper limit of normal, repeat in 2-4 weeks
- If elevation persists or is ≥3-fold the upper limit, consider gastroenterology consultation and/or vibration-controlled transient elastography
Referral Criteria
- Immediate referral for unexplained jaundice or suspected hepatic/biliary malignancy 1
- Refer to specialist clinic for: 1
- Positive hepatitis B (HBsAg positive)
- Positive hepatitis C (antibody positive then PCR positive)
- Autoimmune hepatitis (raised IgG ± positive autoantibodies)
- Primary biliary cholangitis (cholestatic enzymes + positive anti-mitochondrial antibody)
- Primary sclerosing cholangitis (cholestatic enzymes ± history of inflammatory bowel disease)
- Hemochromatosis (raised ferritin and transferrin saturation >45%)
- Presence of dilated bile ducts on imaging
Common Pitfalls to Avoid
- Do not simply repeat the same panel of tests without investigating the cause - this is inefficient and delays diagnosis 1
- Do not assume that the magnitude of liver enzyme elevation correlates with prognosis - clinical significance is determined by the specific analyte and clinical context 1
- Do not overlook normal or mildly abnormal liver enzymes - significant liver fibrosis may exist despite normal or only mildly elevated liver enzymes 1
- Do not miss common causes - fatty liver disease, alcohol-related liver damage, and chronic viral hepatitis are the most common causes of abnormal liver function tests in asymptomatic patients 4
- Do not delay pediatric referral - children with abnormal liver tests should have a low threshold for referral to a pediatrician 1